Wilmington Funds Management Corp - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 96 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wilmington Funds Management Corp ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2014$42,000
-12.5%
10,3850.0%0.00%
-20.0%
Q1 2014$48,000
-4.0%
10,385
-9.8%
0.01%0.0%
Q4 2013$50,000
-59.7%
11,511
-80.6%
0.01%
-58.3%
Q2 2013$124,00059,2200.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2014
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$38,182,0007.99%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 10,406,850$26,225,0004.02%
MILLER VALUE PARTNERS, LLC 12,385,586$31,211,0001.12%
CHIRON CAPITAL MANAGEMENT, LLC 201,470$508,0000.41%
Sargent Investment Group, LLC 289,025$728,0000.26%
MAGNOLIA CAPITAL ADVISORS LLC 80,542$404,0000.16%
XTX MARKETS LLC 11,086$28,0000.14%
Virtus ETF Advisers LLC 99,108$250,0000.13%
Old West Investment Management, LLC 210,226$529,0000.12%
EQUITEC PROPRIETARY MARKETS, LLC 31,300$79,0000.06%
View complete list of ZIOPHARM ONCOLOGY INC shareholders